Tags » Aurobindo Pharma

iClick2Share-14: Buy Aurobindo, Target Rs.652

We are pleased to share our very special service with the purpose of making short-term gains in the stock market to the investor.

iClick2Share

Post 14… 139 more words

Personal Finance

Indian Pharma Stocks: Cheap or Not

Indian Pharma is down in the dumps and does not see any hope for a turnaround around any time soon. However, analyzing the Pharma companies namely  we were intrigued to see the valuations from a price to book perspective.  96 more words

Stock Views

iClick2Share - 05

We are pleased to share our very special service with the purpose of making short-term gains in the stock market to the investor.

iClick2Share

Post 05… 146 more words

Equity

Stocks of Infosys, ICICI Bank, HDFC Among Others, are in the News Today

Infosys Ltd has on 19 Aug. 2017 sanctioned a proposal to buyback equity shares for an amount not exceeding Rs 13,000 cr. The buyback will include a purchase of up to 11.30 cr, shares aggregating up to 4.92% of the paid up equity capital through tender process at Rs 1,150 per share. 152 more words

Share Market

Aurobindo Pharma looks to sell cancer drugs in the US by year end

Hyderabad-based pharma major says US FDA approval likely to come after upcoming audit

Company News : Hyderabad-based Aurobindo Pharma Limited is hoping to receive three-four product approvals in the oncology space from the US Food and Drug Administration (US FDA) before March 2018. 230 more words